Literature DB >> 10086946

Partial remission phase of diabetes in children younger than age 10 years.

B J Muhammad1, P G Swift, N T Raymond, J L Botha.   

Abstract

There is renewed interest in the phase of partial remission in recently diagnosed diabetes because of the potential for pharmacological and immune intervention to preserve beta cell function. 95 children younger than 10 years were investigated to assess the influence of age, sex, diabetic ketoacidosis (DKA), admission at diagnosis, and ethnicity on the frequency of remission and insulin requirements during the first two years after diagnosis. Partial remission was defined as a requirement of insulin < 0.5 U/kg body weight/day. There was partial remission in 41 patients, with no differences for children aged 2-4 years and those aged 5-9 years. None of the five children aged < 2 years remitted. Forty five of 95 children were admitted to hospital at diagnosis, of whom 26 of 45 had DKA (blood pH < 7.25). In this number of children we were unable to show a statistical difference in the rate of remission with respect to DKA, admission to hospital at diagnosis, sex, or South Asian ethnic background. There were no differences in insulin requirements between the different groups by the end of two years and at that time seven of the children required insulin < 0.5 U/kg/day. The results suggest that even in preschool children there is potential for attempting to preserve beta cell function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10086946      PMCID: PMC1717883          DOI: 10.1136/adc.80.4.367

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  16 in total

1.  High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM.

Authors:  O Schnell; B Eisfelder; E Standl; A G Ziegler
Journal:  Diabetes       Date:  1997-10       Impact factor: 9.461

2.  The early partial remission of juvenile diabetes mellitus. The roles of insulin and growth hormone.

Authors:  L Baker; R Kaye; A W Root
Journal:  J Pediatr       Date:  1967-12       Impact factor: 4.406

Review 3.  Outpatient versus inpatient care of children newly diagnosed with IDDM.

Authors:  D Charron-Prochownik; T Maihle; L Siminerio; T Songer
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

4.  Evidence of an accelerated B-cell destruction in HLA-Dw3/Dw4 heterozygous children with type 1 (insulin-dependent) diabetes.

Authors:  M Knip; J Ilonen; A Mustonen; H K Akerblom
Journal:  Diabetologia       Date:  1986-06       Impact factor: 10.122

5.  beta-cell function in children with diabetes.

Authors:  J Ludvigsson; L G Heding
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

6.  Insulin prophylaxis in individuals at high risk of type I diabetes.

Authors:  R J Keller; G S Eisenbarth; R A Jackson
Journal:  Lancet       Date:  1993-04-10       Impact factor: 79.321

7.  Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas.

Authors:  J Mirouze; J L Selam; T C Pham; E Mendoza; A Orsetti
Journal:  Diabetologia       Date:  1978-04       Impact factor: 10.122

8.  Postinitial remission in diabetic children--an analysis of 178 cases.

Authors:  M Knip; A Säkkinen; N P Huttunen; M L Käär; S Länkelä; A Mustonen; H K Akerblom
Journal:  Acta Paediatr Scand       Date:  1982-11

9.  Effect of genetic risk load defined by HLA-DQB1 polymorphism on clinical characteristics of IDDM in children.

Authors:  R Veijola; M Knip; H Reijonen; P Vähäsalo; R Puukka; J Iionen
Journal:  Eur J Clin Invest       Date:  1995-02       Impact factor: 4.686

10.  Insulin dependent diabetes in under 5 year olds.

Authors:  I G Jefferson; M A Smith; J D Baum
Journal:  Arch Dis Child       Date:  1985-12       Impact factor: 3.791

View more
  17 in total

Review 1.  Infant and toddler diabetes.

Authors:  Declan Cody
Journal:  Arch Dis Child       Date:  2007-08       Impact factor: 3.791

2.  Association of adiponectin, interleukin (IL)-1ra, inducible protein 10, IL-6 and number of islet autoantibodies with progression patterns of type 1 diabetes the first year after diagnosis.

Authors:  A Kaas; C Pfleger; L Hansen; K Buschard; N C Schloot; B O Roep; H B Mortensen
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

3.  Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis.

Authors:  Maria J Redondo; Crystal G Connor; Katrina J Ruedy; Roy W Beck; Craig Kollman; Jamie R Wood; Bruce Buckingham; Georgeanna J Klingensmith; Janet Silverstein; William V Tamborlane
Journal:  Pediatr Diabetes       Date:  2013-07-24       Impact factor: 4.866

Review 4.  Acquired non-type 1 diabetes in childhood: subtypes, diagnosis, and management.

Authors:  J R Porter; T G Barrett
Journal:  Arch Dis Child       Date:  2004-12       Impact factor: 3.791

5.  Partial Clinical Remission of Type 1 Diabetes Mellitus in Children: Clinical Applications and Challenges with its Definitions.

Authors:  Benjamin Udoka Nwosu
Journal:  Eur Med J Diabetes       Date:  2019-03-14

6.  Dynamic changes in CD4+ CD25+(high) T cell apoptosis after the diagnosis of type 1 diabetes.

Authors:  S Glisic-Milosavljevic; T Wang; M Koppen; J Kramer; S Ehlenbach; J Waukau; P Jailwala; S Jana; R Alemzadeh; S Ghosh
Journal:  Clin Exp Immunol       Date:  2007-08-17       Impact factor: 4.330

7.  A pilot study showing associations between frequency of CD4(+) memory cell subsets at diagnosis and duration of partial remission in type 1 diabetes.

Authors:  Rosita Moya; Hannah Kathryn Robertson; Dawson Payne; Aditi Narsale; Jim Koziol; Joanna Davida Davies
Journal:  Clin Immunol       Date:  2016-04-22       Impact factor: 3.969

8.  Unraveling the contribution of pancreatic beta-cell suicide in autoimmune type 1 diabetes.

Authors:  Majid Jaberi-Douraki; Santiago Schnell; Massimo Pietropaolo; Anmar Khadra
Journal:  J Theor Biol       Date:  2014-05-14       Impact factor: 2.691

9.  Immune Regulation in T1D and T2D: Prospective Role of Foxp3+ Treg Cells in Disease Pathogenesis and Treatment.

Authors:  Mara Kornete; Edward S Mason; Ciriaco A Piccirillo
Journal:  Front Endocrinol (Lausanne)       Date:  2013-06-25       Impact factor: 5.555

10.  New definition for the partial remission period in children and adolescents with type 1 diabetes.

Authors:  Henrik B Mortensen; Philip Hougaard; Peter Swift; Lars Hansen; Reinhard W Holl; Hilary Hoey; Hilde Bjoerndalen; Carine de Beaufort; Francesco Chiarelli; Thomas Danne; Eugen J Schoenle; Jan Aman
Journal:  Diabetes Care       Date:  2009-05-12       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.